Stocks
Axsome Therapeutics (AXSM) Operating Income US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -179.8 | -179.8 | -231.8 | -280.6 | -169.2 | -175.6 | |||
| Changes by years, y/y, % | +44% | 0% | +29% | +21% | -40% | +11.3% | |||
Axsome Therapeutics. Operating Income, bln rub
Axsome Therapeutics. Operating Income, changes, %
Axsome Therapeutics. Operating Income, sum by quarters, bln rub
Axsome Therapeutics (AXSM) Operating Income US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Operating Income, bln rub | -57.0 | -36.7 | -46.1 | -29.4 | -63.4 | -175.6 | ||
| Changes by years, y/y, % | -15% | -53% | -26% | -59% | +11% | |||
| Changes by quarters, q/q, % | -22% | -36% | +26% | -36% | +115% | |||
